Guidant, Boston Scientific Agree To Settle Patent Suits, Exchange Licenses
This article was originally published in The Gray Sheet
Executive Summary
A comprehensive patent settlement between Boston Scientific and Guidant, announced May 17, covers all current patent litigation pending between the two companies, including coronary stent systems and dilatation catheters. The deal also includes cross licensing of "certain patents" related to the litigation.